Alnylam Pharmaceuticals Earnings
NASDAQ: ALNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$1.68
Alnylam Pharmaceuticals earnings summary
Alnylam Pharmaceuticals is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $1.68. In its most recent report on Jul 30, 2026 (Q2 2026), ALNY posted EPS of $1.21. Revenue for the quarter was $1.29 billion.
Across the last 16 reports, ALNY shares moved an average of 6.9% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
ALNY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $1.21 | — | +6.7% |
| Feb 12, 2026 | — | $1.18 | — | +6.9% |
| Oct 30, 2025 | — | $1.84 | — | -2.9% |
| Jul 31, 2025 | — | $-0.55 | — | +9.2% |
| May 1, 2025 | — | $-0.14 | — | -3.2% |
| Feb 13, 2025 | — | $-0.66 | — | -2.3% |
| Oct 31, 2024 | — | $-0.87 | — | +1.3% |
| Aug 1, 2024 | — | $-0.13 | — | -0.9% |
| May 2, 2024 | — | $-0.52 | — | -1.2% |
| Feb 15, 2024 | — | $-1.06 | — | +7.2% |
| Nov 2, 2023 | — | $1.15 | — | -3.3% |
| Aug 3, 2023 | — | $-2.21 | — | +0.1% |
| May 4, 2023 | — | $-1.40 | — | -3.2% |
| Feb 23, 2023 | — | $-1.69 | — | +6.7% |
| Oct 27, 2022 | — | $-3.32 | — | +1.9% |
| Jul 28, 2022 | — | $-2.29 | — | +53.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.